Synthio LabsYC P25 landing page report.
← Back to YC P25

Your landing page’s weakest score is Trust.

Fix Trust

Score over time

8070605040Veeva Systems 62 on Jun 2 (Wayback)Veeva Systems 44 on Jun 14 (Wayback)Veeva Systems 63 on Jun 27 (Wayback)Veeva Systems 61 on Jul 11 (Wayback)Veeva Systems 62 on Aug 4 (Wayback)Veeva Systems 52 on Sep 2 (Wayback)Veeva Systems 54 on Sep 20 (Live)Exeevo 71 on Sep 20 (Live)ODAIA 66 on Apr 20 (Wayback)ODAIA 48 on May 16 (Wayback)ODAIA 64 on May 28 (Wayback)ODAIA 45 on Sep 1 (Wayback)ODAIA 63 on Sep 20 (Live)Trueblue (AI-driven pharma commercial platform) 49 on Sep 20 (Live)Synthio Labs 62 on Apr 7 (Wayback)Synthio Labs 63 on Apr 28 (Wayback)Synthio Labs 65 on May 10 (Wayback)Synthio Labs 64 on Jun 15 (Wayback)Synthio Labs 64 on Sep 20 (Live)Apr 7Apr 28May 10Jun 15Sep 20
Past reportsShow past reportsHide past reports
  1. Sep 20, 202664LiveTrust −4 · Mobile web +4Viewing
  2. Jun 15, 202664Overall −1 · Information hierarchy −6View →
  3. May 10, 202665Overall +2 · Value props +6 · Information hierarchy +4View →
  4. Apr 28, 202663Overall +1 · Information hierarchy +4 · Value props −4View →
  5. Apr 7, 202662First tracked report — strongest Mobile web 82, weakest Trust 38View →

Trust

34Poor

Proof that the product is real, competent, and safe to try.

Exeevo
Veeva Systems
Trueblue (AI-driven pharma commercial platform)
Trust read
Synthio LabsNo visible trust signal identified.
Veeva SystemsAnnouncement banner: "Veeva Announces Falcon, Agentic Labor for Drug Development"
ExeevoDetailed product UI mockup on tablet and phone showing CRM calendar, contacts, call plans, and approval workflows
ODAIANo visible trust signal identified.
Trueblue (AI-driven pharma commercial platform)"Soluzioni integrate basate su tecnologie Microsoft" — Microsoft technology anchor in the subhead

Value props

58Fair

Title, subtitle, hero — do they sell the product's true value?

Synthio Labs’s headline vaguePharma teams of the future run on SynthioThe intelligence layer powering modern pharma GTM teams across HCP Engagement, Patient Support, Field Enablement, Marketing and Commercial Ops

Working

  • Names exact audience: pharma GTM teams
  • Subhead lists five concrete use cases
  • Confident, category-owning tone

Could improve

  • Headline states identity, not outcome
  • No numbers or proof anywhere in fold
  • Hero render decorates, never demonstrates

CTA

68Fair

Copy, size, verb, cost-feel — does the primary CTA earn the click?

Synthio Labs
Exeevo
ODAIA

Problems

  • demo booking feels costly
  • no low-commitment alternative
  • secondary CTA diverts to blog

Information hierarchy

72Fair

Does the design help or inhibit what the page is trying to say?

Information hierarchy annotations on the desktop capture1234
  1. Duplicate BOOK A DEMO — Nav's black 'BOOK A DEMO' outweighs the hero CTA of the same name, splitting the primary action into two equal targets.
  2. Blog card panel — The 'Read the blog' card sits directly under the hero CTA and pulls attention to an exit before conversion.
  3. Seven-item nav row — Products, Platform, Customers, Resources, Careers, and Safety give six exit paths at the same eye level as the CTA.
  4. Nav overlaps hero image — Careers and Safety links render over the light hero artwork edge, reducing legibility and blurring the header boundary.

Mobile web

86Strong

The phone experience as a first-class citizen.

Mobile web annotations on the mobile capture12
  1. Blog card text — Two-line headline crammed into a small tile makes the secondary CTA hard to parse.
  2. Dotted-arrow ornament — Decorative glyph before "run on Synthio" adds clutter and no meaning at phone size.